Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jan 4, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Notice of Pre-Application Webinar for RFA-DK-21-034, Analysis, Technology, Leadership, Administration and Science (ATLAS) Center (U24 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Clarification of Reporting Requirements for Animal Welfare Act Regulated Institutions, "Guidance on Flexibilities for Conducting Semiannual Inspections of Animal Facilities"
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice to Expire NOSIs to PAR-19-070, "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)"
National Institute on Aging
- Notice to Expire NOSIs to PAR-19-071, "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)"
National Institute on Aging
- Notice of NCI's Participation in PAR-20-070, "Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)"
National Cancer Institute
- Notice to Extend the Response Date for NOT-CA-22-004 "Request for Information (RFI): Seeking Input on Technology Needs for Cancer Control and Population Sciences Researchers"
National Cancer Institute
- Notice of NHLBI Participation in PAR-21-169 Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- Notice of NHLBI Participation in PAR-21-173 - "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)"
National Heart, Lung, and Blood Institute
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Complementary and Integrative Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
Requests for Proposal
- Request for Proposals FNIH Cancer Steering Committee Project Concepts for Novel Biomarker Platforms to Support Novel Tissue Imaging, Remote Sensing, and Toxicity Challenges
National Cancer Institute
Notices of Special Interest
- Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging
National Institute on Aging
- Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pain, Pain Management, and Opioids in Aging
National Institute on Aging
- Notice of Special Interest: NCCIH High Priority Pain Research
National Center for Complementary and Integrative Health
- Notice of Special interest (NOSI): Medications Development for Stimulant Use Disorders
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Promoting Fundamental Research on Mitochondrial Involvement in Lung Diseases and Sleep Disorders
National Heart, Lung, and Blood Institute
- Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Special Interest (NOSI): Diagnostics and Disease Management Tools for Use in Underserved Populations
National Heart, Lung, and Blood Institute
- Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
National Cancer Institute
National Human Genome Research Institute
National Institute on Aging
National Institute of Environmental Health Sciences
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
- Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women's Health
- Notice of Special Interest (NOSI): NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional)
National Institute of Mental Health
- Notice of Special Interest (NOSI): Pain-Focused Administrative Supplements for NINDS Grants that are Not Focused on Pain Research
National Institute of Neurological Disorders and Stroke
Funding Opportunities
- NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)
National Institute on Aging
- Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
- Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
National Institute on Aging
- Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
National Institute on Aging
- Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
National Institute on Aging
- HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed)
- HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
- PBPK Modeling to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract (U01) Clinical Trial Optional
Food and Drug Administration
- Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional
Food and Drug Administration
- Cutaneous Pharmacokinetics (PK) Based Approaches to Demonstrate Bioequivalence of Topical Products (U01) Clinical Trial Required
Food and Drug Administration
- Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
- Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
National Institute of Mental Health
National Institute on Aging
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.